FDA News Digest
May 27, 2008
_____________________________________
IN THIS WEEK'S ISSUE
» News
-- Drug Approved to Help Restore Bowel Function After Surgery
» Consumer Health Information
Drug Approved to Help Restore Bowel Function After Surgery
FDA has approved Entereg (alvimopan) to accelerate the restoration of normal bowel function in patients 18 years and older who have undergone partial large- or small-bowel resection surgery. Entereg will be used in hospitalized patients who can receive no more than 15 doses. FDA approved Entereg with a Risk Evaluation and Mitigation Strategy (REMS) to ensure that the benefits of the drug outweigh the risks. The REMS will include limits on dispensing of the drug.
To access the RSS feed of FDA news releases, go to http://www.fda.gov/bbs/topics/news/rssPress.xml. [What is an RSS feed? See http://www.fda.gov/bbs/topics/news/newsfeeds.html.]
_____________________________________________
Safety Alerts:
FDA is warning consumers not to use or purchase Mommy's Bliss Nipple Cream, marketed by MOM Enterprises, Inc., because the product contains potentially harmful ingredients that may cause respiratory distress or vomiting and diarrhea in infants. The product is promoted to nursing mothers to help soothe and heal dry or cracked nipples. Product labeling states that there is no need for mothers to remove the cream prior to nursing. However, the ingredients contained in the product may be harmful to nursing infants.
http://www.fda.gov/bbs/topics/NEWS/2008/NEW01839.html
FDA has requested that Miami-based SEI Pharmaceuticals recall all Xiadafil VIP Tabs sold in 8-tablet bottles (Lot # 6K029) or blister cards of 2 tablets (Lot # 6K029-SEI) because these products contain a potentially harmful, undeclared ingredient that may dangerously affect blood pressure and can cause other life-threatening side effects. These lots of Xiadafil VIP Tabs bear an expiration date of September 2009 (09/09). Xiadafil VIP Tabs are marketed as a dietary supplement for sexual enhancement and to treat erectile dysfunction.
For a list of recalls, market withdrawals, and safety alerts involving FDA-regulated products from the past 60 days, go to http://www.fda.gov/opacom/7alerts.html.
To access the RSS feed of FDA recalls information, go to http://www.fda.gov/oc/po/firmrecalls/rssRecalls.xml [What is an RSS feed? See http://www.fda.gov/bbs/topics/news/newsfeeds.html.] UPCOMING PUBLIC MEETINGS
May 29 -- Dermatologic and Ophthalmic Drugs Advisory Committee
Under discussion: pending application for new drug proposed to treat inflammation and pain following eye surgery
Location: Rockville, Md.
http://edocket.access.gpo.gov/2008/E8-8351.htm
May 30 -- Science Board to FDA
Under discussion: keeping pace with scientific and technical evolutions in regulatory science
Location: Gaithersburg, Md.
http://edocket.access.gpo.gov/2008/E8-10257.htm
May 30 -- Oncologic Drugs Advisory Committee
Under discussion: pending application for a new drug treatment to increase platelet counts and reduce or prevent bleeding in certain patients
Location: Chicago
http://edocket.access.gpo.gov/2008/E8-10258.htm
For a complete list of upcoming meetings, seminars, and other public events sponsored or co-sponsored by FDA, go to http://www.fda.gov/opacom/hpmeetings.html.
This week's spotlight consumer updates are:
http://www.fda.gov/consumer/updates/statins051608.html
To receive all consumer updates by e-mail, go to http://www.fda.gov/consumer/consumerenews.html.
For the latest in consumer health news from FDA, visit http://www.fda.gov/consumer/default.htm.
Thanks for subscribing to FDA News Digest.
Comments about FDA News Digest?
Send an e-mail to fdanewsdigest@xxxxxxxxxv.
Update your subscriptions, modify your e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact support@xxxxxxxxxxxxxxx.
This service is provided to you at no charge by U.S. Food & Drug Administration (FDA).
GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420
